PT - JOURNAL ARTICLE AU - Qijun Gao AU - Fangfang Bie AU - Yinfu Hu AU - Yafeng Chen AU - Bo Yang TI - Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction AID - 10.1101/2021.09.21.21263421 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.21.21263421 4099 - http://medrxiv.org/content/early/2021/10/07/2021.09.21.21263421.short 4100 - http://medrxiv.org/content/early/2021/10/07/2021.09.21.21263421.full AB - Background There are few studies on the characteristics and mechanism of reciprocal ST-segment depression(RSTD) in acute myocardial infarction.Methods The electrocardiogram and angiography of 85 STEMI patients were retrospectively analyzed to summarize the characteristics of ST segment changes and explore the mechanism of RSTD.Results A total of 85 patients were included, of which 75 were patients with RSTD (10 patients with anterior myocardial infarction had no RSTD), all 45 patients with inferior myocardial infarction had limb leads RSTD, and 37 of them had anterior lead ST segment depression.Thirty patients with anterior myocardial infarction were accompanied by mild ST segment changes in the limb leads. According to the characteristics of RSTD, it is speculated that the mechanism of RSTD is that the action potential of infarct area decreased, which could not offset the action potential in non-infarct area. All ST segment changes in STEMI can be explained by the proposed mechanism, and the value of the ST segment changes can be calculated in limb leads.Conclusion the mechanism of RSTD in acute myocardial infarction is that the negative electrode action potential of the lead was weakened or disappeared, and the positive electrode action potential could not be completely offset, resulting in ST segment depression.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialunnecessaryFunding StatementnoAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the No.1 Hospital of Jingmen ethics committee and oral consent was obtained from patients.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll information may be obtained by contacting the author of the newsletter https://m0.mail.sina.com.cn/classic/index.php#action=maillist&fid=unk&title&pagecount=0&pageno=1&order=htime&sorttype=desc&type=0&tag=-1